Carmot Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Carmot Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10938
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company that discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company provides product portfolio such as encompasses investigational candidates in preclinical trials: peptide-small molecule hybrid compounds that target Nonalcoholic Steatohepatitis NASH. It offers products such as protein-protein interactions NEMO and IKK for the treatment of cancer and inflammation; and GLP-1R and GIPR for treating Type 2 diabetes and obesity, among others. Carmot Therapeutics proprietary technology, Chemotype Evolution applies to identify and optimize innovative drugs for various therapeutic areas. The company works in collaboration with research institutions and companies such as Amgen Inc and Genentech for discovery of new drugs. Carmot Therapeutics is headquartered in Berkeley, California, the US.

Carmot Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Carmot Therapeutics Raises USD15 Million in Series B Financing 10
Carmot Therapeutics Raises USD10.8 Million in Venture Financing 11
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 12
Licensing Agreements 13
Amgen Enters into Licensing Agreement with Carmot Therapeutics 13
Amgen Expands its Licensing Agreement with Carmot Therapeutics 14
Genentech Enters into Licensing Agreement with Carmot Therapeutics 15
Carmot Therapeutics Inc – Key Competitors 16
Carmot Therapeutics Inc – Key Employees 17
Carmot Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carmot Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Carmot Therapeutics Raises USD15 Million in Series B Financing 10
Carmot Therapeutics Raises USD10.8 Million in Venture Financing 11
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 12
Amgen Enters into Licensing Agreement with Carmot Therapeutics 13
Amgen Expands its Licensing Agreement with Carmot Therapeutics 14
Genentech Enters into Licensing Agreement with Carmot Therapeutics 15
Carmot Therapeutics Inc, Key Competitors 16
Carmot Therapeutics Inc, Key Employees 17
Carmot Therapeutics Inc, Other Locations 18

List of Figures
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Carmot Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Electric Power Co:企業の戦略的SWOT分析
    National Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Centrica Plc (CNA)-石油・ガス分野:企業M&A・提携分析
    Summary Centrica plc (Centrica) is an integrated energy company. It carries out electricity generation through and combined cycle gas turbine (CCGT) power stations, and nuclear power plants through its stake in EDF Energy Nuclear Generation. Centrica secures and supply gas and electricity to homes a …
  • Holidaybreak Ltd:企業の戦略・SWOT・財務情報
    Holidaybreak Ltd - Strategy, SWOT and Corporate Finance Report Summary Holidaybreak Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • West Fraser Timber Co. Ltd. (WFT):企業の財務・戦略的SWOT分析
    West Fraser Timber Co. Ltd. (WFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Callitas Therapeutics Inc (LILY):製薬・医療:M&Aディール及び事業提携情報
    Summary Callitas Therapeutics Inc (Callitas Therapeutics), formerly M Pharmaceutical Inc, is a drug discovery and development company that offers ground-breaking drug treatments and biomedical technologies. The company’s products include weight management products, infertility products and women’s h …
  • NS Solutions Corp (2327):企業の財務・戦略的SWOT分析
    NS Solutions Corp (2327) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Newfield Exploration Co (NFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Newfield Exploration Co (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The company …
  • Mega Financial Holding Co., Ltd.:企業の戦略・SWOT・財務情報
    Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Novavax, Inc.:企業のM&A・事業提携・投資動向
    Novavax, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novavax, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • IDT Australia Ltd (IDT)-製薬・医療分野:企業M&A・提携分析
    Summary IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes i …
  • Dauntless Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dauntless Pharmaceuticals Inc (Dauntless Pharma) is a drug development company that develops therapeutic agents. The company’s pipeline products include DP1038 and DP2018. Its DP1038 is an intranasal octreotide formulation used as a therapeutic agent for the treatment of acromegaly and neuro …
  • African Development Bank Group:企業の戦略的SWOT分析
    African Development Bank Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • James Fisher and Sons Plc (FSJ):石油・ガス:M&Aディール及び事業提携情報
    Summary James Fisher and Sons Plc (James Fisher) is a service provider for global marine industry and a specialist supplier of engineering services to the energy industry. The company provides comprehensive services such as design and engineering; inspection and monitoring; lifting and handling; mar …
  • Kiromic Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kiromic Inc (Kiromic) is a biotechnology company focused on developing immuno-oncology therapies. Its pipeline products include BSK01, an injectable drug that harness dendritic cells for the treatment of solid and hematological malignancies; BSK02, a synthetic oral cancer immunotherapy compo …
  • Therapeutic Solutions International Inc (TSOI)-医療機器分野:企業M&A・提携分析
    Summary Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that provides supplement products. The company offers ProJuvenol, T-Rx and Vital. Its ProJuvenol consists of anti-aging ingredients which helps for a healthy functionality for everyday living and prom …
  • Centrais Eletricas de Santa Catarina S.A. (CLSC4):企業の財務・戦略的SWOT分析
    Centrais Eletricas de Santa Catarina S.A. (CLSC4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • NIH Office of Technology Transfer:製薬・医療:M&Aディール及び事業提携情報
    Summary NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biolog …
  • AutoNation, Inc. (AN):企業の財務・戦略的SWOT分析
    AutoNation, Inc. (AN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sabre Corporation (SABR):企業の財務・戦略的SWOT分析
    Sabre Corporation (SABR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Chiome Bioscience Inc (4583)-製薬・医療分野:企業M&A・提携分析
    Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that offers research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating system …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆